MTSL Issue 847

 Comments Off on MTSL Issue 847
Mar 052017
 
MTSL Issue 847

MTSL Issue 847 (dated 3/02/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #BMRN #CELG #FPRX #INCY #XON #IONS #MDCO #NKTR #PCRX #SGMO

MTSL Issue 844

 Comments Off on MTSL Issue 844
Jan 222017
 
MTSL Issue 844

MTSL Issue 844 (dated 1/19/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #BMRN #CELG #INCY #IONS #MDCO #NKTR #PCRX #SGMO #ZIOP

MTSL Issue 841

 Comments Off on MTSL Issue 841
Dec 042016
 
MTSL Issue 841

MTSL Issue 841 (dated 12/1/16) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #MDGL #SGMO

MTSL Issue 839

 Comments Off on MTSL Issue 839
Nov 062016
 
MTSL Issue 839

MTSL Issue 839 (dated 11/03/16) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #ALKS #BMRN #INCY #XON #IONS #MDCO #OGXI #SGMO #ZIOP

MTSL Issue 835

 Comments Off on MTSL Issue 835
Sep 112016
 
MTSL Issue 835

MTSL Issue 835 (dated 9/8/16) of Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis & updates from these companies: #ANTH #BMRN #XON #MDCO #SGMO

MTSL Issue 833

 Comments Off on MTSL Issue 833
Aug 142016
 
MTSL Issue 833

MTSL Issue 833 (dated 8/11/16) of Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis & updates from these companies: #ACAD #ANTH #BMRN #FPRX #INCY #XON #IONS #MDCO #NKTR #NVAX #PCRX #SGMO #ZIOP

MTSL Issue 832

 Comments Off on MTSL Issue 832
Jul 312016
 
MTSL Issue 832

MTSL Issue 832 (dated 7/28/16) of Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis & updates from these companies: #ALKS #BMRN #INCY #MDCO #SGMO

MTSL Issue 829

 Comments Off on MTSL Issue 829
Jun 122016
 
MTSL Issue 829

MTSL Issue 829 (dated 6/09/16) of the Medical Technology #Stock Letter from BioInvest includes the #Biotech Sector Analysis as well as updates from the following companies: #ALKS #FPRX #INCY #IONS #XON #NVAX #MDCO #SGMO #ZIOP

MTSL Issue 817

 Comments Off on MTSL Issue 817
Dec 202015
 
MTSL Issue 817

Issue No. 817 (dated 12/17/15) of the Medical Technology Stock Letter from BioInvest includes the Biotech Sector Analysis as well as updates from the following companies found in the MTSL Portfolio: #ANTH #ALKS #MDCO #NKTR #NVAX #OGXI #PCRX SGMO #ZIOP

MTSL Issue 816

 Comments Off on MTSL Issue 816
Dec 062015
 
MTSL Issue 816

Issue No. 816 (dated 12/3/15) of the Medical Technology Stock Letter from BioInvest includes the Biotech Sector Analysis as well as updates from the following companies found in the MTSL Portfolio: #BMRN #XON #MDCO #NKTR #NVAX #OGXI #SGMO #ZIOP

Sangamo Update (2-13-13)

 Comments Off on Sangamo Update (2-13-13)
Feb 132013
 
Sangamo Update (2-13-13)

QUARTERLY UPDATE – stock has been volatile since the release of their financials last week (2/7). However, given that the stock has had an incredible start to 2013 (still up >50% YTD), a pullback was not unexpected, and the shares have since made an impressive recovery.  Pullbacks after very strong moves that back and fill […]

Sangamo Update (1-18-13)

 Comments Off on Sangamo Update (1-18-13)
Jan 182013
 
Sangamo Update (1-18-13)

Sangamo’s stock has risen sharply (~35%) since their presentation last week at the JP Morgan conference. The company broadly explained what their novel technology – In Vivo Protein Replacement – has the ability to accomplish.  It has the ability to mechanistically, physically, and permanently change a single disease related gene (“monogenic”) and, therefore, has substantial […]

Sangamo Update (1-18-13)

 Comments Off on Sangamo Update (1-18-13)
Jan 182013
 
Sangamo Update (1-18-13)

OUTLOOK 2013 – THE OPEN-ENDED POTENTIAL OF ZFPS SGMO’s stock has exploded since their presentation last week at the JP Morgan conference.  The company began the presentation by broadly explaining what their technology can accomplish.  The ability to actually mechanistically, physically, and permanently change a single disease related gene (monogenic) has huge potential.  SGMO’s technology […]